An Inpatient Study Of The Efficacy, Safety, And Tolerability Of PF-02545920 In The Treatment Of Acute Exacerbation Of Schizophrenia
Public ClinicalTrials.gov record NCT01175135. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Double-blind, Randomized, Parallel Group, 4-week Inpatient Study To Evaluate The Safety And Efficacy Of Two Fixed Doses Of Pf-02545920 Compared To Placebo In The Treatment Of Acute Exacerbation Of Schizophrenia Using Risperidone As An Active Control
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study aims to evaluate whether PF-02545920 is safe and effective in the treatment of acute exacerbation of schizophrenia during a 4-week inpatient treatment period. The study will use the Positive and Negative Syndrome Scale (PANSS) to measure change in symptoms for PF-02545920 compared to risperidone and placebo treatment.
Study identification
- NCT ID
- NCT01175135
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 259 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2010 (Actual)
- Primary completion
- Aug 2011 (Actual)
- Completion
- Aug 2011 (Actual)
- Last update posted
- May 22, 2018
2010 – 2011
United States locations
- U.S. sites
- 38
- U.S. states
- 14
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| K & S Professional Research Services, LLC | Little Rock | Arkansas | 72201 | — |
| Leisure Court Center | Anaheim | California | 92801 | — |
| Early Phase Investigational Center | Escondido | California | 92025 | — |
| Synergy Clinical Research Center of Escondido | Escondido | California | 92025 | — |
| Collaborative Neuroscience Network, Inc. | Garden Grove | California | 92845 | — |
| Ocean View Psychiatric Health Facility | Long Beach | California | 90806 | — |
| Long Beach VA Healthcare System | Long Beach | California | 90822 | — |
| University of California Irvine Medical Center | Orange | California | 92868 | — |
| California Clinical Trials Medical Group | Paramount | California | 90723 | — |
| LaPaz Geropsychiatric Center | Paramount | California | 90723 | — |
| Sharp Mesa Vista Hospital | San Diego | California | 92123 | — |
| Neuropsychiatric Research Center of Orange County | Santa Ana | California | 92701 | — |
| Collaborative Neuroscience Network, Inc. | Torrance | California | 90502 | — |
| Del Amo Hospital | Torrance | California | 90505 | — |
| Comprehensive Neuroscience, Incorporated | Washington D.C. | District of Columbia | 20016 | — |
| Florida Clinical Research Center, LLC | Bradenton | Florida | 34208 | — |
| Florida Clinical Research Center, LLC | Maitland | Florida | 32751 | — |
| Lakeside Behavioral Healthcare | Orlando | Florida | 32810 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30308 | — |
| Alexian Brothers Behavioral Health Hospital | Hoffman Estates | Illinois | 60169 | — |
| Alexian Brothers Center for Psychiatric Research | Hoffman Estates | Illinois | 60169 | — |
| Chinmay K. Patel, D.O. | Hoffman Estates | Illinois | 60169 | — |
| Lake Charles Memorial Hospital | Lake Charles | Louisiana | 70601 | — |
| Lake Charles Clinical Trials | Lake Charles | Louisiana | 70629 | — |
| CBH Health, LLC | Rockville | Maryland | 20850 | — |
| St. Louis Clinical Trials, LC | St Louis | Missouri | 63118 | — |
| CRI Worldwide, LLC | Willingboro | New Jersey | 08046 | — |
| Lourdes Medical Center of Burlington County | Willingboro | New Jersey | 08046 | — |
| Comprehensive Neuroscience, Inc. | Hollis | New York | 11423 | — |
| CRI Worldwide, LLC | Philadelphia | Pennsylvania | 19139 | — |
| FutureSearch Trials | Austin | Texas | 78731 | — |
| TexasNeuroRehab Center | Austin | Texas | 78745 | — |
| Community Clinical Research | Austin | Texas | 78754 | — |
| InSite Clinical Research | DeSoto | Texas | 75115 | — |
| Bayou City Research, Ltd. | Houston | Texas | 77007 | — |
| Behavioral Hospital - Bellaire | Houston | Texas | 77081 | — |
| Eastside Therapeutic Resource | Kirkland | Washington | 98033 | — |
| Fairfax Hospital | Kirkland | Washington | 98034 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01175135, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 22, 2018 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01175135 live on ClinicalTrials.gov.